Clinical Trial Update: Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the subcutaneous pharmacokinetics of monomeric insulin and Lyumjev in adults with Type 1 diabetes; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lyumjev (insulin lispro)
• Monomeric insulin (insulin monomer)

Snippet

Sponsor: Stanford University | Conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus | Phase 1 | Status: RECRUITING